This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Progen Pg500 Series Pty Ltd, Progen Pharmaceuticals, Inc.. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2018
Title: Paul Newton Handley: Innovator in Sulfated Oligosaccharide Derivatives
Introduction
Paul Newton Handley is a notable inventor based in Goodna, Australia. He has made significant contributions to the field of biochemistry, particularly through his innovative work on sulfated oligosaccharide derivatives. With a total of 2 patents, Handley's inventions have the potential to impact various medical treatments.
Latest Patents
Handley's latest patents focus on novel compounds that serve as inhibitors of heparan sulfate-binding proteins. These compounds and their compositions are designed for use in antiangiogenic, antimetastatic, anti-inflammatory, antimicrobial, anticoagulant, and/or antithrombotic treatments for mammalian subjects. The implications of these inventions are vast, offering new avenues for therapeutic interventions.
Career Highlights
Throughout his career, Paul Newton Handley has worked with prominent companies in the pharmaceutical industry, including Progen Pharmaceuticals, Inc. and Progen Pg500 Series Pty Ltd. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.
Collaborations
Handley has collaborated with notable colleagues such as Vito Ferro and Tomislav Karoli. These partnerships have fostered a creative environment that has led to the development of groundbreaking inventions.
Conclusion
Paul Newton Handley's contributions to the field of biochemistry through his patents on sulfated oligosaccharide derivatives highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile